OXB — Oxford BioMedica Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Oxford BioMedica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	C2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	32.2	16.2	46.7	109	141
Net Total Accounts Receivable
Net Total Receivables	28.6	33.6	51.4	42.1	57.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	65.9	56.9	108	164	216
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31.8	61.9	72.3	69.7	134
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	112	123	184	237	460
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.5	28.9	52.5	33.3	59.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	77.7	47.3	71.2	49.9	256
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	34.7	75.6	113	187	205
Total Liabilities & Shareholders' Equity	112	123	184	237	460
Total Common Shares Outstanding